Clinical Microbiology Reviews, Oct 1995, 451-461, Vol 8, No. 4
CC Kuo, LA Jackson, LA Campbell and JT Grayston
Chlamydia pneumoniae (TWAR) is a recently recognized third species of the
genus Chlamydia that causes acute respiratory disease. It is distinct from
the other two chlamydial species that infect humans, C. trachomatis and C.
psittaci, in elementary body morphology and shares less than 10% of the DNA
homology with those species. The organism has a global distribution, with
infection most common among children between the ages of 5 and 14 years. In
children, TWAR infection is usually mild or asymptomatic, but it may be
more severe in adults. Pneumonia and bronchitis are the most common
clinical manifestations of infection, and TWAR is responsible for
approximately 10% of cases of pneumonia and 5% of cases of bronchitis in
the United States. The microimmunofluorescence serologic assay is specific
for TWAR and can distinguish between recent and past infections. The
organism can be isolated in cell culture; however, PCR techniques have
recently facilitated its detection in tissues and clinical specimens.
Copyright © 1995 by the American Society for Microbiology. All rights reserved.
Chlamydia pneumoniae (TWAR)
Department of Pathobiology, University of Washington, Seattle 98195, USA.
This article has been cited by other articles:
| Antimicrob. Agents Chemother. | Clin. Vaccine Immunol. |
|---|---|
| J. Clin. Microbiol. | ALL ASM JOURNALS |